Clearance Summary
DIABETES CARE(TM) TEST PACKAGE FOR THE CLC 330(TM) received FDA 510(k) clearance under submission number K896582, sponsored by Primus, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1990-06-28.
- Submission: K896582
- Applicant / Sponsor: Primus, Inc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7470
- Decision date: 1990-06-28
Classification & Regulation
This clearance is catalogued under FDA product code LCP and 21 CFR 864.7470, within the Hematology review panel as a Class II device.